Tasca Therapeutics

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to develop small molecule drugs for hard-to-treat oncology indications. Tasca Therapeutics is based in Cambridge, MA and was founded in 2022. It was valued at $83.3 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $67 million across 1 recorded round; the latest was a $48.1 million early-stage round in Nov 2024.

PMV mark · valuation
$83.3M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$67.0M
Last round
Early Stage VC
Nov 2024
What is Tasca Therapeutics worth?
$83.3MPrivateMarketView mark · Oct 2026

Valued at $83.3M at its early-stage round, Sep 2025. Nothing has traded since.

Free account
More of Tasca Therapeutics with a free account
  • ·Watch Tasca Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Tasca Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Nov 2024Early Stage VC$48.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Tasca Therapeutics valuation

Tasca Therapeutics was valued at $83.3 million at its early-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Tasca Therapeutics raised?

Tasca Therapeutics has raised $67 million in total; 1 of its rounds is on record. The largest on record was a $48.1 million early-stage round in Nov 2024.

Tasca Therapeutics has filed 1 Form D with the SEC, most recently in Nov 2024 ($24.1 million sold to 7 investors).

How Tasca Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Tasca Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Tasca Therapeutics

What is Tasca Therapeutics worth?
Tasca Therapeutics is valued at $83.3M as of Oct 2026. Valued at $83.3M at its early-stage round, Sep 2025. Nothing has traded since.
How much has Tasca Therapeutics raised?
Tasca Therapeutics has raised $67.0M in total funding across 1 recorded rounds.
When did Tasca Therapeutics last raise?
Tasca Therapeutics last raised in Nov 2024 (Early Stage VC), raising $48.1M.